|
Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Competitor Analysis.
Volume 4, Issue 44: Anti-Interferon /-Receptor Antibodies for Autoimmune Diseases
Target Pipeline:
- Anti-Interferon /-Receptor Antibodies for Autoimmune Diseases
Company Pipelines:
- Amgen (US)
- Solvay Pharmaceuticals (Belgium)
More Details inside R&D Pipeline News
Get your annual subscription and receive this issue for free!
R&D Pipeline News
Get your Subscription Now
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.
- The Technology Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week as a PDF directly to your desktop via e-mail.
- The Therapeutic Area Edition lists the News in groups according to the Therapautic Area, e.g. oncology, neurology, etc
|
